HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preventing carbon nanoparticle-induced lung inflammation reduces antigen-specific sensitization and subsequent allergic reactions in a mouse model.

AbstractBACKGROUND:
Exposure of the airways to carbonaceous nanoparticles can contribute to the development of immune diseases both via the aggravation of the allergic immune response in sensitized individuals and by adjuvant mechanisms during the sensitization against allergens. The cellular and molecular mechanisms involved in these adverse pathways are not completely understood. We recently described that the reduction of carbon nanoparticle-induced lung inflammation by the application of the compatible solute ectoine reduced the aggravation of the allergic response in an animal system. In the current study we investigated the influence of carbon nanoparticles on the sensitization of animals to ovalbumin via the airways. Ectoine was used as a preventive strategy against nanoparticle-induced neutrophilic lung inflammation.
METHODS:
Balb/c mice were repetitively exposed to the antigen ovalbumin after induction of airway inflammation by carbon nanoparticles, either in the presence or in the absence of ectoine. Allergic sensitization was monitored by measurement of immunoglobulin levels and immune responses in lung and lung draining lymph nodes after challenge. Furthermore the role of dendritic cells in the effect of carbon nanoparticles was studied in vivo in the lymph nodes but also in vitro using bone marrow derived dendritic cells.
RESULTS:
Animals exposed to antigen in the presence of carbon nanoparticles showed increased effects with respect to ovalbumin sensitization, to the allergic airway inflammation after challenge, and to the specific TH2 response in the lymph nodes. The presence of ectoine during the sensitization significantly reduced these parameters. The number of antigen-loaded dendritic cells in the draining lymph nodes was identified as a possible cause for the adjuvant effect of the nanoparticles. In vitro assays indicate that the direct interaction of the particles with dendritic cells is not able to trigger CCR7 expression, while this endpoint is achieved by lung lavage fluid from nanoparticle-exposed animals.
CONCLUSIONS:
Using the intervention strategy of applying ectoine into the airways of animals we were able to demonstrate the relevance of neutrophilic lung inflammation for the adjuvant effect of carbon nanoparticles on allergic sensitization.
AuthorsMatthias Kroker, Ulrich Sydlik, Andrea Autengruber, Christian Cavelius, Heike Weighardt, Annette Kraegeloh, Klaus Unfried
JournalParticle and fibre toxicology (Part Fibre Toxicol) Vol. 12 Pg. 20 (Jul 04 2015) ISSN: 1743-8977 [Electronic] England
PMID26141115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amino Acids, Diamino
  • Anti-Inflammatory Agents
  • Ccr7 protein, mouse
  • Chemokine CXCL1
  • Cxcl1 protein, mouse
  • Interleukin-13
  • Receptors, CCR7
  • Interleukin-4
  • Carbon
  • ectoine
  • Ovalbumin
Topics
  • Amino Acids, Diamino (pharmacology)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Carbon (toxicity)
  • Cells, Cultured
  • Chemokine CXCL1 (immunology, metabolism)
  • Dendritic Cells (drug effects, immunology, metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Interleukin-13 (immunology, metabolism)
  • Interleukin-4 (immunology, metabolism)
  • Lung (drug effects, immunology, metabolism)
  • Lymph Nodes (drug effects, immunology, metabolism)
  • Macrophages (drug effects, immunology, metabolism)
  • Mice, Inbred BALB C
  • Nanoparticles
  • Neutrophils (drug effects, immunology, metabolism)
  • Ovalbumin
  • Pneumonia (chemically induced, immunology, metabolism, prevention & control)
  • Receptors, CCR7 (immunology, metabolism)
  • Respiratory Hypersensitivity (chemically induced, immunology, metabolism, prevention & control)
  • Th2 Cells (drug effects, immunology, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: